Azobenzenes
- (18)
- (1)
- (1)
- (11)
- (1)
- (4)
- (1)
- (1)
- (40)
- (1)
- (2)
- (24)
- (2)
- (5)
- (1)
- (3)
- (1)
- (8)
- (2)
- (2)
- (1)
- (5)
- (2)
- (4)
- (2)
- (1)
- (1)
- (3)
- (2)
- (1)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (5)
- (4)
- (2)
- (1)
- (1)
- (1)
- (7)
- (1)
- (1)
- (2)
- (2)
- (2)
- (4)
- (2)
- (1)
- (2)
- (1)
- (5)
- (1)
- (1)
- (1)
- (3)
- (1)
- (3)
- (1)
- (4)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (81)
- (2)
- (2)
- (7)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (3)
- (2)
- (7)
- (3)
- (2)
- (6)
- (7)
- (1)
- (6)
- (17)
- (2)
- (5)
- (6)
- (7)
- (1)
- (1)
- (6)
- (2)
- (1)
Filtered Search Results
Medchemexpress LLC 3H-pyrrolo[2,3-d]pyrimidine-4,6-dione derivative (pentafluoropropoxy, trifluoroethoxy phenyl) | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor provided as a high-purity research compound for in vitro and in vivo studies. The compound shows low-nanomolar potency and includes solubility and formulation guidance in the datasheet and COA.
- Selective delta-5 desaturase inhibitor with human IC50 22 nM and rat IC50 72 nM.
- High reported purity: 99.9% (LCMS).
- Molecular weight 473.27; formula C17H11F8N3O4.
- Supplied as 50 MG research quantity.
- DMSO solubility 125 mg/mL; in vivo formulation protocols provided.
- Quality supported by an accompanying COA and datasheet.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC D5D-IN-326 | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor used in preclinical research. It demonstrates low-nanomolar potency in enzymatic and cell-based assays and has been reported to improve metabolic parameters in diet-induced obese mice. Documentation typically includes a product datasheet, certificate of analysis, and safety data sheet.
- Selective delta-5 desaturase inhibition with low-nanomolar potency.
- Demonstrated activity in enzymatic and cell-based assays.
- Reduces insulin resistance and body weight in preclinical mouse models.
- High purity (99.9% by LC-MS) confirmed by certificate of analysis.
- Supplied as a small-molecule research reagent with supporting documentation for reproducibility.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 78957-85-4 | Medchem Express | A-3 (hydrochloride) | 10mg | 533802412 | HY-125957 | MFCD00077311 | 321.22 | C12H14Cl2N2O2S
Medchem Express | A-3 (hydrochloride) | 10mg | 533802412 | HY-125957 | 78957-85-4 | MFCD00077311 | 321.220 | C12H14Cl2N2O2S
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 2-(2,2,3,3,3-pentafluoropropoxy)-3-(4-(2,2,2-trifluoroethoxy)phenyl)-5,7-dihydropyrrolopyrimidine-4,6-dione | 1236767-85-3 | 99.9% | 473.27 | C17H11F8N3O4 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor supplied as a powder for research use. It shows low-nanomolar potency (IC50 22 nM human, 72 nM rat), has molecular weight 473.27, and is reported at high purity (99.9%). Preclinical studies indicate improved insulin sensitivity and weight reduction in diet-induced obese mice. Store and handle per the manufacturer's recommendations.
- Selective delta-5 desaturase inhibitor with low-nanomolar potency.
- High purity suitable for pharmacology studies (99.9%).
- Powder form, convenient for formulation and dosing.
- Suitable for in vitro and in vivo pharmacology studies.
- Certificate of analysis and safety data sheet available.
- Defined storage conditions for powder and solutions to preserve stability.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Chromeceptin 5mg | 331859-86-0 | 359.35 g·mol⁻1 | C19H16F3N3O | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Chromeceptin is a small-molecule research inhibitor of the IGF signaling pathway that suppresses IGF2 expression and reduces phosphorylation of AKT and mTOR in hepatocyte and hepatocellular carcinoma cells. Supplied for preclinical laboratory use.
- IGF signaling pathway inhibitor.
- Suppresses IGF2 expression at mRNA and protein levels.
- Reduces phosphorylation of AKT and mTOR.
- High chemical purity suitable for preclinical research.
- Available in milligram pack sizes and DMSO solution formats for convenient dosing.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atuliflapon (AZD5718) | 2041075-86-7 | 99.0% | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atuliflapon is an orally active FLAP (5-lipoxygenase activating protein) inhibitor used as a research tool to modulate leukotriene production and study inflammatory and cardiovascular biology.
- Oral FLAP inhibitor with low-nanomolar potency in enzyme/binding assays.
- Inhibits LTB4 production in human whole blood (IC50 ≈ 39 nM); binding Kd ≈ 4.4 nM in assay reports.
- Chemical formula C24H26N6O3 and molecular weight 446.50 g/mol.
- High purity (≈99.0%) suitable for in vitro studies.
- Available as solids and as DMSO solutions (examples: 10 mg solid; 10 mM, 1 mL in DMSO).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC WR99210 50mg | 47326-86-3 | 394.7 g/mol | C14H18Cl3N5O2 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
WR99210 is a potent dihydrofolate reductase (DHFR) inhibitor used in antiparasitic research and as a selection reagent for Plasmodium transfection. It is supplied as a research-grade free base and is used in laboratory studies that require selective inhibition of parasite DHFR.
- Potent dihydrofolate reductase (DHFR) inhibition with subnanomolar activity.
- Commonly used as a selection reagent for Plasmodium transfection experiments.
- Provided as the free base form suitable for research applications.
- Typical pack size: 50 mg.
- For research use only; not for human or clinical use.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 844470-86-6 | ChemScene | 1-(3-Fluorophenyl)propan-1-amine hydrochloride | 100mg | 712788533 | CS-0432862 | MFCD28126471 | 189.66 | C9H13ClFN
ChemScene | 1-(3-Fluorophenyl)propan-1-amine hydrochloride | 100mg | 712788533 | CS-0432862 | 844470-86-6 | MFCD28126471 | 189.660 | C9H13ClFN
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 2049872-86-6 | Medchem Express | GSK962 | 5mg | 489862907 | HY-103028 | 230.311 | C14H18N2O
Ambeed | 5-Amino-246-triiodoisophthaloyl dichloride | 1g | 601097172 | A330595 | 37441-29-5 | MFCD00270836 | 595.720 | C8H2Cl2I3NO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules AstaTech / (S)-4-ISOBUTYLOXAZOLIDIN-2-ONE / 0.25g / 411872068 / AC1174 / 95.000 / 17016-85-2 / MFCD06656594 / 143.186 / C7H13NO2
AstaTech / (S)-4-ISOBUTYLOXAZOLIDIN-2-ONE / 0.25g / 411872068 / AC1174 / 95.000 / 17016-85-2 / MFCD06656594 / 143.186 / C7H13NO2
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 947669-86-5 | Medchem Express | WWL113 | 5mg | 713704307 | HY-110148 | MFCD28160857 | 466.537 | C29H26N2O4
Medchem Express | WWL113 | 5mg | 713704307 | HY-110148 | 947669-86-5 | MFCD28160857 | 466.537 | C29H26N2O4
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules AstaTech / ISOPROPYL(2-NITROPHENYL)SULFANE / 0.25g / 434269003 / W12996 / 95.000 / 70415-85-9 / MFCD13689000 / 197.250 / C9H11NO2S
AstaTech / ISOPROPYL(2-NITROPHENYL)SULFANE / 0.25g / 434269003 / W12996 / 95.000 / 70415-85-9 / MFCD13689000 / 197.250 / C9H11NO2S
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC P32 inhibitor M36 | 802555-85-7 | MFCD31666371 | 98.6% | 448.52 g·mol-1 | C23H28N8O2 | 25MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
p32 inhibitor M36 is a small-molecule research reagent that binds directly to the mitochondrial p32 (C1QBP) protein and blocks its association with LyP-1, enabling biochemical and cell-based studies investigating p32-related pathways such as proliferation and viability.
- Binds directly to mitochondrial p32 protein.
- Inhibits p32 association with LyP-1.
- Suitable for cell-based and biochemical assays.
- High purity for research applications.
- Supplied as a solid, convenient for storage and handling.
- Molecular formula C23H28N8O2; molecular weight 448.52 g·mol-1.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 185259-85-2 | Medchem Express | GR-46611 | 5mg | 724441955 | HY-101248 | MFCD00953517 | 377.488 | C23H27N3O2
Medchem Express | PARP10|15-IN-3 | 5mg | 761041080 | HY-146502 | 2892064-88-7 | 274.320 | C15H18N2O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC FzM1.8 50mg | 2204290-85-5 | 322.31 g/mol | C18H14N2O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
FzM1.8 is a small-molecule allosteric agonist of the Frizzled receptor FZD4 that activates the WNT/β-catenin signaling pathway by promoting TCF/LEF transcriptional activity in the absence of WNT ligand. The compound is provided as a research-grade, purified material with reported physicochemical and handling data suitable for in vitro and in vivo studies.
- Allosteric agonist of FZD4 that activates the WNT/β-catenin pathway.
- Suitable for in vitro and in vivo research applications.
- High reported purity (98.93%) for reproducible results.
- Molecular formula C18H14N2O4 and molecular weight 322.31 g/mol.
- Soluble in DMSO (≈83.33 mg/mL) and formulatable for in vivo dosing.
- Recommended storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (2 years).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More